drospirenone and ethinyl estradiol combination has been researched along with Insulin Resistance in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodur, S; Dundar, O; Kanat-Pektas, M; Kinci, MF; Tutuncu, L | 1 |
| Aguiar, GS; Bonfleur, ML; Boschero, AC; Clarke, JR; da Silva Junior, JA; Dos Reis Araujo, T; Freitas, IN; Henriques, HN; Oliveira, CAR; Oliveira, KM; Ribeiro, RA; Vettorazzi, JF | 1 |
| Sun, X; Wu, X; Yu, X; Zhang, W; Zhou, Y | 1 |
| Decavalas, G; Diamanti-Kandarakis, E; Georgopoulos, NA; Katsikis, I; Panidis, D; Piouka, A; Saltamavros, AD | 1 |
2 trial(s) available for drospirenone and ethinyl estradiol combination and Insulin Resistance
| Article | Year |
|---|---|
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study.
Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult | 2018 |
The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Anti-Mullerian Hormone; Blood Glucose; Body Mass Index; Cohort Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Practice Guidelines as Topic; Young Adult | 2011 |
2 other study(ies) available for drospirenone and ethinyl estradiol combination and Insulin Resistance
| Article | Year |
|---|---|
Combined oral contraceptive in female mice causes hyperinsulinemia due to β-cell hypersecretion and reduction in insulin clearance.
Topics: Androstenes; Animals; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose; Hyperinsulinism; Insulin; Insulin Resistance; Insulin-Secreting Cells; Mice | 2019 |
Evaluation of Apelin and Insulin Resistance in Patients with PCOS and Therapeutic Effect of Drospirenone-Ethinylestradiol Plus Metformin.
Topics: Adult; Androstenes; Apelin; Blood Glucose; Body Mass Index; Case-Control Studies; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Metformin; Polycystic Ovary Syndrome; Reproductive Control Agents; Young Adult | 2015 |